gvtcx

Ex-ante appraisal for ERDF investment into an Urban Development Fund

LOCAL PARTNERSHIPS LLP Published 1 Apr 2016 Contracts Finder

key details

Value£30,000
Statusactive
Category (CPV) 79400000 +3 more
RegionNorth West
Deadline25 Apr 2016
Contract start9 May 2016
Contract end8 Aug 2016
Procedureopen
SME suitableYes
OCIDocds-b5fd17-80fb726f-adc9-11e6-9901-0019b9f3037b

description

The areas of Cheshire and Warrington and Lancashire need to evidence, to the satisfaction of DCLG, the case for distributing ERDF through an Urban Development Fund in accordance with the allocations identified in their European Structural and Investment Fund (ESIF) Strategies. They therefore need to complete an ex-ante appraisal to consider, firstly, the question of whether there is a market failure in the investment priorities that is sufficient to justify the commitment of ERDF funds and, secondly, the nature of the products required to address that market failure (e.g. debt, equity etc). In addition, Cheshire and Warrington are currently considering their investment strategy for deploying £12.1m of recycled Growing Places Fund (GPF). The ex-ante appraisal should therefore also consider to what extent this funding could be deployed to complement potential ERDF eligible developments across Cheshire and Warrington or help address access to finance issues for ERDF ineligible development such as retail and residential schemes.

Additional information: Please see Contact Details for further background information

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
18 Nov 2016 Tender (tender) · e89c4940-1331-449a-b90e-7c82fcc951ca-92544

more from LOCAL PARTNERSHIPS LLP

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.